We are live on
!
Find out more
HMH
Hackensack Meridian Health Portfolio holdings
AUM
$1.48B
1-Year Est. Return
21%
This Fund
S&P 500
This Quarter
Est. Return
-2.68%
1 Year Est. Return
+21%
3 Year Est. Return
+53.43%
5 Year Est. Return
–
10 Year Est. Return
–
AUM
$958M
AUM Growth
-$72.5M
(-7%)
Cap. Flow
-$41.5M
Cap. Flow
% of AUM
-4.33%
Top 10 Holdings %
Top 10 Hldgs %
100%
Holding
9
New
2
Increased
1
Reduced
2
Closed
–
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
iShares MSCI ACWI ETF
ACWI
|
+$94.7M |
| 2 |
iShares Biotechnology ETF
IBB
|
+$29.7M |
| 3 |
State Street SPDR S&P Global Natural Resources ETF
GNR
|
+$15.2M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
iShares MSCI EAFE ETF
EFA
|
+$161M |
| 2 |
iShares iBoxx $ Investment Grade Corporate Bond ETF
LQD
|
+$20M |
Sector Composition
| Rank | Sector | Weight |
|---|
Similar funds
AE
TCA
CFIA
FA
SI
WAG
PIA
TAM
Hackensack Meridian Health's Q1 2022 Portfolio in Review
As of Q1 2022, Hackensack Meridian Health held 9 positions worth $958M, down 7% from $1.03B the previous quarter. Its ten largest holdings account for 100% of the portfolio.
Hackensack Meridian Health withdrew a net $41.5M in Q1 2022, reducing 2 holdings. Its largest reduction was iShares MSCI EAFE ETF, cutting an estimated $161M.
Against the trend, Hackensack Meridian Health opened a new position in iShares MSCI ACWI ETF worth $94.8M.
- Hackensack Meridian Health's largest Q1 2022 buy was iShares MSCI ACWI ETF: 950,000 shares worth $94.8M.
- Hackensack Meridian Health added most to State Street SPDR S&P Global Natural Resources ETF in Q1 2022, an estimated $15.2M increase.
- Hackensack Meridian Health's biggest Q1 2022 reduction was iShares MSCI EAFE ETF, cutting an estimated $161M.
- Hackensack Meridian Health's ten largest holdings make up 100% of its $958M portfolio in Q1 2022.
- Hackensack Meridian Health opened 2 new positions and closed 0 in Q1 2022.
- Hackensack Meridian Health's portfolio value fell 7% quarter-over-quarter to $958M.
Based on Hackensack Meridian Health's 13F filing for Q1 2022, filed 16 May 2022.